期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
准分子激光冠状动脉成形术治疗支架内再狭窄 被引量:3
1
作者 刘梅林 周荣兴 +1 位作者 郭安庆 M.h.jim 《中国介入心脏病学杂志》 2000年第2期75-77,共3页
目的 评价准分子激光冠状动脉 (ELCA)加球囊成形术 (PTCA)治疗冠脉内支架再狭窄的有效性及安全性。方法 自 1996年 10月至 1998年 2月对 2 0例支架内再狭窄病人进行ELCA +PT CA治疗 ,其中男 17例、女 3例 ,平均年龄 (6 1± 8 7)... 目的 评价准分子激光冠状动脉 (ELCA)加球囊成形术 (PTCA)治疗冠脉内支架再狭窄的有效性及安全性。方法 自 1996年 10月至 1998年 2月对 2 0例支架内再狭窄病人进行ELCA +PT CA治疗 ,其中男 17例、女 3例 ,平均年龄 (6 1± 8 7)岁。所有病人均有Ⅲ、Ⅳ级心绞痛 (加拿大心脏病协会分级 )。共有 2 3个支架 ,其中 2例病人为一根血管多个支架 ,支架直径为 2 5~ 3 5mm。选用同心型和偏心型激光导管 ,直径 1 4~ 2 0mm。激光能量范围为 40~ 6 0mJ/mm2 ,平均 (45 7± 5 5 )mJ/mm2 。所有病人于ELCA后行球囊成形术 ,球囊直径 2 5~ 4 0mm ,扩张压力为 (6~ 12 )atm ,平均 (7 8±2 0 )atm。结果 激光导管可顺利通过所有狭窄甚至闭塞病变。应用冠状动脉形象分析 (QCA)测量病变长度为 4 6~ 5 1 2mm ,平均 (2 0 7± 13 7)mm ,其中 14个病变≥ 10mm。ELCA后最小血管直径(MLD)自 (0 3± 0 3)mm增至 (1 4± 0 3)mm(P <0 0 0 0 1) ,血管狭窄程度自 (88 9± 10 ) %降至 (46 0±8 0 ) % (P <0 0 0 0 1)。球囊成形后使MLD进一步增加至 (2 3± 0 7)mm(P <0 0 0 0 1) ,血管狭窄程度降至 (14 2± 8 2 ) % (P <0 0 0 1)。所有病人手术成功 ,无严重并发症。 1例病人在ELCA +PTCA后效果不理想 。 展开更多
关键词 准分子激光冠脉成形术 再狭窄 治疗 心脏病
下载PDF
Treatment of in stent coronary restenosis with excimer laser angioplasty
2
作者 Meilin Liu W.h.Chow +4 位作者 O.h.Kwok M.h.jim A.Yip K.Fan E.Chan 《Chinese Medical Journal》 SCIE CAS CSCD 2000年第1期14-17,共4页
OBJECTIVE: To evaluate the efficacy and safety of excimer laser coronary angioplasty (ELCA) with adjunctive balloon angioplasty in patient with in-stent restenosis. METHODS: ELCA was performed in 20 patients of insten... OBJECTIVE: To evaluate the efficacy and safety of excimer laser coronary angioplasty (ELCA) with adjunctive balloon angioplasty in patient with in-stent restenosis. METHODS: ELCA was performed in 20 patients of instent restenosis. All patients were symptomatic and had class III-IV angina. ELCA was performed with the Spectranetics CVX-300 System. The laser catheter of Vittesse C (concentric) and E (eccentric) with diameter of 1.4-2.0 mm was used. RESULTS: Laser catheter crossed all stenotic stents without difficulty. The lesion length was 4.6-51.2 mm, mean 20.7 +/- 13.7 mm, including 14 lesions > 10 mm. Laser treatment alone increased minimal lumen diameter (MLD) from 0.3 +/- 0.3 mm to 1.4 +/- 0.3 mm (P 展开更多
关键词 Angioplasty Balloon Laser-Assisted STENTS Aged Aged 80 and over Angioplasty Transluminal Percutaneous Coronary Coronary Restenosis FEMALE Humans Male Middle Aged
原文传递
Allophane as a Nanotechnological Additive in Masonry Materials to Increase Resistance and Waterproofing
3
作者 Edward h. jiménez Joao Rivera +10 位作者 Juan h. Villalba Paola E. Vera Marlon Cuenca Belén Granja Javier Fuentes Sandra Gavilanes Daniel hidalgo Fernando Garcia Jose Bermudez Washington Ruiz Alexis Martial Debut 《Advances in Materials Physics and Chemistry》 CAS 2024年第8期196-212,共17页
The constant need for high-strength materials in the construction industry promotes the research of additives that improve the properties of masonry materials. The use of allophane as an additive in concrete and morta... The constant need for high-strength materials in the construction industry promotes the research of additives that improve the properties of masonry materials. The use of allophane as an additive in concrete and mortar mixtures was implemented to improve their strength and waterproofing, respectively, using compression and water absorption tests according to their corresponding standards (ASTM C1231, ASTM D2938, and ASTM C1585). The samples were evaluated at different concentrations and curing ages. In addition, different sand/cement ratios were considered for the mortar. The results revealed that there was a 9.4% increase in compressive strength in concrete and a 23.7% reduction in water absorption in mortar for the 5:1 ratio. These changes would be the result of the interaction of the nanoporous additive in the atomic crystal structure of the material demonstrating the nanotechnological nature of allophane. 展开更多
关键词 ALLOPHANE Nano Additive Strength IMPERMEABILITY CONCRETE MORTAR
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部